Mobi-C®
-
Spine
ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
Decision clears the way for enrollment of U.S. patients in a groundbreaking clinical study of cervical arthroplasty adjacent to fusion…
Read More » -
Regulatory
ZimVie Announces FDA Approval for New Mobi-C® Implant
Smaller height implants in all Mobi-C footprints to address patient anatomy WESTMINSTER, Colo., Aug. 10, 2023 (GLOBE NEWSWIRE) — ZimVie…
Read More » -
Spine
ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®
Mobi-C obtains French government reimbursement and the highest quality rating from the British clinical data panel ODEP. WESTMINSTER, Colo., April…
Read More » -
Spine
ZimVie Announces Over 200,000 Cervical Discs Have Been Replaced with Mobi-C®
Milestone aligns with ten-year anniversary of Mobi-C FDA approval for treatment of one and two levels of the cervical spine…
Read More »